Recent studies on GLP-1 have also reported a deceleration in the progression of non-alcoholic fatty liver disease by direct effects on lipid metabolism in hepatocytes, and on liver inflammation. This evidence concerns the gene GLP1R and metabolic dysfunction-associated steatotic liver disease.